Core Nursing Explanation
Key Concept Analysis: This question assesses the critical nursing action for managing
drug-induced hepatotoxicity in a patient undergoing
anti-tuberculosis therapy. The cornerstone of first-line TB treatment (often isoniazid, rifampin, pyrazinamide, ethambutol) is the risk of liver injury. The patient is asymptomatic, but lab values show significant elevation: ALT
120 U/L and AST
110 U/L (normal is typically
< 40 U/L). This is a classic sign of medication toxicity that requires urgent intervention to prevent progression to fulminant hepatitis or liver failure.
Answer Rationale:
Key Point! The most appropriate action is to
hold the medications and notify the healthcare provider immediately. This is a standard safety protocol. The nurse's role is to recognize the abnormal data, protect the patient from further harm by stopping the likely causative agent, and escalate the situation to the provider for definitive management (which may include permanent discontinuation, regimen change, or further testing). Continuing the drugs could lead to irreversible liver damage.
Distractor Analysis:
•
Watch out for confusion! Option ② (Continue and recheck) is dangerous because it delays necessary intervention while the toxic insult continues.
• Option ③ (Reduce isoniazid dose) is incorrect because the nurse
cannot independently adjust medication doses. Furthermore, hepatotoxicity can be caused by any of the first-line drugs, not just isoniazid.
• Option ④ (Administer hepatoprotective agents) is also incorrect. While agents like N-acetylcysteine might be used in specific overdose scenarios, initiating new medications without a provider's order is outside the nurse's scope of practice. The priority is to stop the offending agent first.
Related Concepts: This integrates pharmacology (adverse drug reactions), laboratory interpretation, and the nursing process (assessment and implementation of safety measures). It highlights the principle that
asymptomatic lab abnormalities can still represent a medical emergency requiring prompt action.
Concept Summary
•
Hepatotoxicity Monitoring in TB Therapy: Baseline liver function tests (LFTs) are required before starting treatment. Patients should be educated to report symptoms like nausea, vomiting, jaundice, dark urine, or fatigue. Routine monitoring of LFTs is standard.
•
Action Threshold: Significant elevation (e.g., AST/ALT >3-5 times the upper limit of normal) or the onset of symptoms typically warrants holding medications and notifying the provider.
•
Nursing Responsibility: The nurse is the frontline monitor for adverse effects. Knowing when to hold a medication based on protocol or objective data is a critical safety skill.
Side-by-Side Comparison!
| Scenario | Nursing Action | Rationale |
|---|
| Asymptomatic patient with mildly elevated LFTs (e.g., ALT 60 U/L) | Notify provider; may continue meds with close monitoring per order. | Minor fluctuations can occur; risk-benefit is assessed by provider. |
| Asymptomatic patient with significantly elevated LFTs (as in this question) | Hold meds and notify provider immediately. | High risk of progressive, severe liver injury. Safety first. |
| Symptomatic patient (jaundice, pain) with any elevation in LFTs | Hold meds and notify provider immediately. | Symptoms indicate clinical hepatitis, requiring immediate cessation. |
Anatomy, Physiology & Pharmacology Points
•
Liver Enzymes: ALT (Alanine Aminotransferase) is more liver-specific. AST (Aspartate Aminotransferase) is found in liver, heart, muscle. Elevation indicates hepatocyte injury/damage.
• Drug Metabolism: The liver metabolizes many drugs, including first-line TB medications. Some individuals are "slow acetylators," metabolizing isoniazid more slowly, increasing toxicity risk.
• Common Culprits: Isoniazid and pyrazinamide are most associated with hepatotoxicity. Rifampin can also cause liver issues, especially when combined with isoniazid.
Memory Tips
• Acronym: For TB drug side effects, remember "RIPE" (Rifampin, Isoniazid, Pyrazinamide, Ethambutol) and that "HIP" (Hepatotoxicity for Isoniazid & Pyrazinamide) is a major concern.
• Rule of Thumb: "Stop the drugs, call the doc" when LFTs are high (especially >3x normal) or symptoms appear. Never adjust doses on your own.
High-Frequency NCLEX Topics
NCLEX loves testing medication safety, adverse effects, and priority nursing actions. This scenario combines all three. You must know: 1) The major side effects of high-risk drug classes (like anti-TB meds, chemotherapeutics), 2) How to interpret key lab values, and 3) The correct sequence of action (assess, protect, notify).
Watch Out for Question Variations!
• They could ask for the priority assessment after holding the meds (e.g., assess for signs of liver failure like jaundice, bleeding tendency, mental status changes).
• They could ask which patient teaching point is most important before starting therapy (e.g., report symptoms of hepatitis, avoid alcohol).
• They could present a similar lab finding for a different hepatotoxic drug (e.g., acetaminophen overdose, statins) – the core action of holding the drug and notifying remains the same.